David Zangen

6PUBLICATIONS
32CO-AUTHORS
Cancer geneticsObstetrics and gynaecologyDevelopmental genetics (incl. sex determination)Cancer therapy (excl. chemotherapy and radiation therapy)Socio-economic development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 24, 2026
Reversible Mitochondrial Iron Toxicity in Wolfram Syndrome Type 2 Monogenic Diabetes.

|Jan 24, 2025
A Novel Homozygous BMP15 Mutation Causes Ovarian Dysgenesis and Primary Amenorrhea.

Amitay Cohen, Raffaella Rossetti, Natan Florsheim

|Dec 21, 2023
Spleen function is reduced in individuals with NR5A1 variants with or without a difference of sex development: a cross-sectional study.

Martine Cools, Celien Grijp, Jana Neirinck

|Nov 06, 2023
Dasiglucagon for the Treatment of Congenital Hyperinsulinism: A Randomized Phase 3 Trial in Infants and Children.

Paul S Thornton, Diva D De Leon, Susann Empting

|Sep 23, 2023
Loss of function of FIGNL1, a DNA damage response gene, causes human ovarian dysgenesis.

Natan Florsheim, Larisa Naugolni, Fouad Zahdeh

|May 06, 2022
Youth-onset type 2 diabetes in Israel: A national cohort.

Nehama Zuckerman Levin, Meidan Cohen, Moshe Phillip

Pageof 1